News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
289,192 Results
Type
Article (14963)
Company Profile (301)
Press Release (273922)
Multimedia
Podcasts (71)
Webinars (11)
Section
Business (81397)
Career Advice (165)
Deals (13771)
Drug Delivery (40)
Drug Development (52316)
Employer Resources (31)
FDA (6340)
Job Trends (5538)
News (149427)
Policy (10596)
Tag
Academia (939)
Accelerated approval (15)
Adcomms (14)
Allergies (76)
Alliances (22102)
ALS (116)
Alzheimer's disease (1051)
Antibody-drug conjugate (ADC) (222)
Approvals (6537)
Artificial intelligence (236)
Autoimmune disease (92)
Automation (9)
Bankruptcy (106)
Best Places to Work (4962)
BIOSECURE Act (6)
Biosimilars (99)
Biotechnology (231)
Bladder cancer (103)
Brain cancer (42)
Breast cancer (375)
Cancer (3078)
Cardiovascular disease (242)
Career advice (150)
Career pathing (6)
CAR-T (205)
CDC (5)
Cell therapy (534)
Cervical cancer (15)
Clinical research (44990)
Collaboration (1011)
Company closure (2)
Compensation (539)
Complete response letters (33)
COVID-19 (1116)
CRISPR (80)
C-suite (468)
Cystic fibrosis (108)
Data (4235)
Denatured (13)
Depression (80)
Diabetes (248)
Diagnostics (1487)
Digital health (9)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (161)
Drug pricing (43)
Drug shortages (3)
Duchenne muscular dystrophy (199)
Earnings (32523)
Editorial (23)
Employer branding (4)
Employer resources (29)
Events (52683)
Executive appointments (615)
FDA (7999)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (20)
Funding (895)
Gene editing (167)
Generative AI (18)
Gene therapy (452)
GLP-1 (492)
Government (1200)
Grass and pollen (3)
Guidances (170)
Healthcare (6887)
HIV (21)
Huntington's disease (38)
IgA nephropathy (70)
Immunology and inflammation (177)
Immuno-oncology (24)
Indications (55)
Infectious disease (1223)
Inflammatory bowel disease (151)
Inflation Reduction Act (10)
Influenza (38)
Intellectual property (148)
Interviews (19)
IPO (7658)
IRA (13)
Job creations (890)
Job search strategy (133)
Kidney cancer (9)
Labor market (22)
Layoffs (241)
Leadership (8)
Legal (1446)
Liver cancer (43)
Longevity (10)
Lung cancer (443)
Lymphoma (251)
Machine learning (23)
Management (7)
Manufacturing (328)
MASH (126)
Medical device (2911)
Medtech (2917)
Mergers & acquisitions (6686)
Metabolic disorders (678)
Multiple sclerosis (96)
NASH (13)
Neurodegenerative disease (213)
Neuropsychiatric disorders (62)
Neuroscience (1883)
NextGen: Class of 2025 (2102)
Non-profit (968)
Now hiring (28)
Obesity (295)
Opinion (122)
Ovarian cancer (125)
Pain (92)
Pancreatic cancer (142)
Parkinson's disease (207)
Partnered (12)
Patents (278)
Patient recruitment (272)
Peanut (41)
People (26785)
Pharmaceutical (46)
Pharmacy benefit managers (7)
Phase I (15505)
Phase II (20572)
Phase III (13733)
Pipeline (2521)
Policy (85)
Postmarket research (1004)
Preclinical (6565)
Press Release (35)
Prostate cancer (142)
Psychedelics (47)
Radiopharmaceuticals (225)
Rare diseases (566)
Real estate (1473)
Recruiting (12)
Regulatory (10173)
Reports (19)
Research institute (998)
Resumes & cover letters (21)
Rett syndrome (21)
RNA editing (16)
RSV (19)
Schizophrenia (115)
Series A (163)
Series B (120)
Service/supplier (1)
Sickle cell disease (74)
Special edition (17)
Spinal muscular atrophy (119)
Sponsored (18)
Startups (2002)
State (1)
Stomach cancer (6)
Supply chain (31)
Tariffs (17)
The Weekly (57)
Vaccines (333)
Venture capital (53)
Weight loss (162)
Women's health (23)
Worklife (2)
Date
Today (63)
Last 7 days (366)
Last 30 days (1455)
Last 365 days (18925)
2025 (18404)
2024 (21220)
2023 (23128)
2022 (27582)
2021 (28757)
2020 (24241)
2019 (16930)
2018 (12356)
2017 (14273)
2016 (12303)
2015 (14844)
2014 (10723)
2013 (7730)
2012 (7764)
2011 (7880)
2010 (7634)
Location
Africa (158)
Alabama (64)
Alaska (2)
Arizona (64)
Arkansas (5)
Asia (18441)
Australia (3136)
California (6671)
Canada (1807)
China (691)
Colorado (235)
Connecticut (252)
Delaware (245)
Europe (40326)
Florida (835)
Georgia (209)
Hawaii (2)
Idaho (17)
Illinois (377)
India (32)
Indiana (182)
Iowa (8)
Japan (232)
Kansas (79)
Kentucky (10)
Louisiana (8)
Maine (12)
Maryland (711)
Massachusetts (5285)
Michigan (103)
Minnesota (241)
Mississippi (3)
Missouri (41)
Montana (15)
Nebraska (4)
Nevada (38)
New Hampshire (18)
New Jersey (1921)
New Mexico (12)
New York (1695)
North Carolina (828)
North Dakota (6)
Northern California (3240)
Ohio (175)
Oklahoma (11)
Oregon (22)
Pennsylvania (1232)
Puerto Rico (8)
Rhode Island (25)
South America (220)
South Carolina (9)
Southern California (2622)
Tennessee (41)
Texas (870)
United States (22659)
Utah (92)
Virginia (131)
Washington D.C. (38)
Washington State (563)
West Virginia (1)
Wisconsin (37)
289,192 Results for "c3j therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock
December 9, 2025
·
4 min read
Press Releases
Denali Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants
December 10, 2025
·
3 min read
Press Releases
Denali Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
December 10, 2025
·
4 min read
Press Releases
Aviceda Therapeutics Announces Phase 2b SIGLEC Results for AVD-104 in Geographic Atrophy
December 15, 2025
·
7 min read
Press Releases
Akari Therapeutics Highlights Preclinical Data Demonstrating Therapeutic Potential of Lead Candidate, AKTX-101, for Hard-to-Treat K-Ras Mutant Pancreatic Cancer
December 10, 2025
·
8 min read
Press Releases
Compass Therapeutics to Participate in Upcoming November 2025 Investor Events
November 4, 2025
·
1 min read
Press Releases
Kymera Therapeutics Announces Pricing of Upsized $602 Million Public Offering
December 10, 2025
·
5 min read
Press Releases
U.S. Food and Drug Administration Approves LIB Therapeutics’ LEROCHOL™ (lerodalcibep-liga) for Adults with Elevated LDL Cholesterol
December 15, 2025
·
6 min read
Press Releases
Johnson & Johnson Set to Revolutionize the Treatment of Cancer With the Acquisition of Halda Therapeutics
November 18, 2025
·
6 min read
Press Releases
Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics
December 15, 2025
·
4 min read
1 of 28,920
Next
